Perceptions and Use of Germline Genetic Testing Among Patients With Prostate Cancer
Laura B. Beidler(Dartmouth Institute for Health Policy and Clinical Practice), Christine M. Gunn(Dartmouth Institute for Health Policy and Clinical Practice), Stephanie Loo(Fenway Health), Catharine Wang(Boston University), Mary Nahorniak(Boston University), Gretchen A. Gignac(Boston University), Kimberly Zayhowski(Boston Medical Center)
Cited by 3
Related Papers
Factors Leading to “Detransition” Among Transgender and Gender Diverse People in the United States: A Mixed-Methods Analysis
|LGBT Health|2021|216
The eight essential elements of inclusive STEM high schools
|International Journal of STEM Education|2016|115
Excess Clinical Comorbidity Among HIV-Infected Patients Accessing Primary Care in US Community Health Centers
|Public Health Reports|2017|63
Advantages and challenges of stem cell therapy for osteoarthritis (Review)
|Biomedical Reports|2021|52